Thrombi in acute coronary syndromes: Revisited and revised

Circulation

Volumn 101, Issue 13, 2000, Pages 1619-1626

  Rentrop, K Peter ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b NONE   (United States)

Author keywords

Anticoagulants; Coagulation; Fibrinolysis; Platelets; Thrombus

Indexed keywords

CREATINE KINASE MB; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; SEROTONIN; STREPTOKINASE; THROMBOPLASTIN; THROMBOXANE;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INTRACORONARY INFUSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; Q WAVE; RECANALIZATION; REVIEW; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

EID: 0034603834     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.13.1619     Document Type: Review

References (95)

1. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
2. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
3. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
4. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912;59:2015-2020.
5. Benson RL. The present status of coronary arterial disease. Arch Pathol Lab Med. 1926;2:876-916.
6. Koch W, Kong LC. Ueber die Formen des Coronarverschlusses, die Aenderungen im Coronarkreislauf und die Beziehungen zur Angina pectoris. Beitr Pathol Anat Allg Pathol. 1932;90:21-84.
7. Saphir O, Priest WS, Hamburger WW, Katz LN. Coronary arteriosclerosis, coronary thrombosis, and the resulting myocardial changes: an evaluation of their respective clinical pictures including the electrocardiographic records, based on the anatomical findings. Am Heart J. 1935; 10:567-595.
8. Paterson JC. Vascularization and hemorrhage of the intima of arteriosclerotic coronary arteries. Arch Pathol Lab Med. 1936;22:313-324.
9. Paterson JC. Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombus. Arch Pathol Lab Med. 1938;25:474-487.
10. Branwood AW, Montgomery GL. Observations on the morbid anatomy of coronary artery disease. Scott Med J. 1956;1:367-375.
11. Spain DM, Bradess VA. The relationship of coronary thrombosis to coronary atherosclerosis and ischemic heart disease. Am J Med Sci. 1960;240:701-710.
12. Popper L, Feiks FK. Herzinfarkt und Koronarthrombose. Wien Klin Wochenschr. 1961;73:421-426.
13. Ehrlich JC, Shinohara Y. Low incidence of coronary thrombosis in myocardial infarction. Arch Pathol Lab Med. 1964;78:432-445.
14. Roberts WC. The pathology of acute myocardial infarction. Hosp Pract (Off Ed). 1971;12:89-104.
15. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am J Med. 1972;52:425-443.
16. 125I-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man. Lancet. 1973;1:387-390.
17. Sinapius D. Haeufigkeit und Morphologie der Coronarthrombose und ihre Beziehungen zur antithrombotischen und fibrinolytischen Behandlung. Wien Klin Wochenschr. 1965;43:37-43.
18. Sinapius D. Ueber Wandveraenderungen bei Coronarthrombose: Bemerkungen zur Haeufigkeit, Entstehung und Bedeutung. Wien Klin Wochenschr. 1965;43:875-880.
19. Chapman I. Morphogenesis of occluding coronary artery thrombosis. Arch Pathol Lab Med. 1965;80:256-261.
20. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1966;6:1-17.
21. Chandler AB, Chapman I, Erhardt LR, Roberts WC, Schwartz CJ, Sinapius D, Spain DM, Sherry SW, Ness PM, Simon TL. Coronary thrombosis in myocardial infarction. Am J Cardiol. 1974;34:823-833.
22. Rentrop KP. Development and pathophysiological basis of thrombolytic therapy in acute myocardial infarction, part I, 1912-1977: the controversy over the pathogenetic role of thrombus in acute myocardial infarction. J Intervent Cardiol. 1998;11:255-263.
23. Rentrop KP, Blanke H, Koestering H, Karsch KR. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol. 1979;2:354-363.
24. Rentrop P, Blanke H, Karsch KR, Kaiser H, Koestering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation. 1981;63:307-317.
25. Rentrop KP. Development and pathophysiological basis of thrombolytic therapy in acute myocardial infarction, part II, 1977-1980: the pathogenetic role of thrombus is established by the Goettingen pilot studies of mechanical interventions and intracoronary thrombolysis in acute myocardial infarction. J Intervent Cardiol. 1998;11:265-285.
26. Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation. 1982;66:316-320.
27. Ambrose JA, Winters SL, Stern A, Eng A, Teicholz LE, Gorlin R, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985;5:609-616.
28. Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein J, Rentrop KP, Gorlin R, Fuster V. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol. 1985;6:1233-1238.
29. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-1140.
30. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Seven S, Parodi O, Biagini A, Distante A, Pesola A. Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med. 1978;299: 1271-1277.
31. Folts JD, Crowell EB Jr, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976;54: 365-370.
32. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
33. Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation. 1984; 69:1161-1170.
34. 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Circ Res. 1984;55:642-652.
35. Schmitz JM, Apprill PG, Buja LM, Willerson JT, Campbell WB. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res. 1985;57:223-231.
36. Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation. 1986;73: 572-578.
37. Willerson JT, Campbell WB, Winniford MD, Schmitz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol. 1984;54:1349-1359.
38. Willerson JT, Hillis LD, Winniford M, Buja LM. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol. 1986;8:245-250.
39. 2, and serotonin are possible mediators. Circulation. 1989;79:154-166.
40. Zoldhelyi P, McNatt J, Xu XM, Loose-Mitchell D, Meidell RS, Clubb FJ, Buja LM, Willerson JT, Wu KK. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation. 1996; 93:10-17.
41. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699-708.
42. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
43. Khaja F, Walton JA, Brymer JF, Lo E, Osterberger L, O'Neill WW, Colfer HT, Weiss R, Lee T, Kurian T, Goldberg AD, Pitt B, Goldstein S. Intracoronary fibrinolytic therapy in acute myocardial infarction: report of a prospective randomized trial. N Engl J Med 1983;308:1305-1311.
44. Ong L, Reiser P, Coromilas J, Scherr L, Morrison J. Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction: evidence for spontaneous reperfusion. N Engl J Med. 1983; 309:1-6.
45. De Wood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303: 897-902.
46. Rentrop KP, Smith H, Painter L, Holt J. Changes in left ventricular ejection fraction after intracoronary thrombolytic therapy. Circulation. 1983;68(suppl I):I-55-I-60.
47. Rentrop KP, Feit F, Sherman W, Stecy P, Hosat S, Cohen M, Rey M, Ambrose J, Nachamie M, Schwartz W, Cole W, Perdoncin R, Thornton JC. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol. 1989;14:58-64.
48. Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, Horowitz S, Goldman M, Karsch K, Meilman H, Cohen M, Siegel S, Sanger J, Slater J, Gorlin R, Fox A, Fagerstrom R, Calhoun WF. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med. 1984;311:1457-1463.
49. Vatner SF, Baig H, Manders WT, Maroko PR. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest. 1978;61:1048-1056.
50. De Wood MA, Stifter WF, Simpson CS, Spores J, Eugster GS, Judge TP, Hinnen ML. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med. 1986;315:417-423.
51. De Wood MA, Spores J, Hensley GR, Simpson CS, Eugster GS, Sutherland KI, Grunwald RP, Shields JP. Coronary arteriographic findings in acute transmural myocardial infarction. Circulation. 1983;68(suppl I):I-39-I-49.
52. Rentrop KP, Feit F, Sherman W, Thornton JC. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction: report from the Second Mount Sinai-New York University Reperfusion Trial. Circulation. 1989;80:1166-1175.
53. Gibson RS. Clinical, functional, and angiographic distinctions between Q-wave and non-Q-wave myocardial infarction: evidence of spontaneous reperfusion and implications for intervention trials. Circulation. 1987; 75(suppl V):V-128-V-138.
54. Freifeld AG, Schuster EH, Bulkley BH. Nontransmural versus transmural myocardial infarction: a morphologic study. Am J Med. 1983;75: 423-432.
55. Gorlin R, Fuster V, Ambrose JA. Anatomic-physiologic links between acute coronary syndromes. Circulation. 1986;74:6-9.
56. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death, I: myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977;56:786-792.
57. Blanke H, von Hardenberg D, Cohen M, Kaiser H, Karsch KR, Holt J, Smith H Jr, Rentrop P. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: comparison with conventional treatment and correlation with infarct size. J Am Coll Cardiol. 1984;3:675-680.
58. Blanke H, Scherff F, Karsch KR, Levine RA, Smith H, Rentrop P. Electrocardiographic changes after streptokinase-induced recanalization in patients with acute left anterior descending artery obstruction. Circulation. 1983;68:406-412.
59. Sinapius D. Thrombogenese in Arterien. Med Welt. 1976;27:1225-1227.
60. Sinapius D. The role of platelets in arterial thrombosis. In: Blood Vessels. Berlin, Germany: Springer Verlag; 1976:35-37.
61. Hampton JR. The potential of thrombolysis in the treatment of thrombotic coronary occlusion. Circulation. 1969;39(suppl IV):IV-231-IV-237.
62. Baumgartner HR. New aspects in thrombogenesis. Vasa. 1974;3:60-64.
63. Sinapius D. Zur Morphologie verschliessender Koronarthromben. Dtsch Med Wochenschr. 1972;97:544-551.
64. Zollinger HU, Papacharalampous N. Ueber das appositionelle proximale Wachstum der Coronarthrombosen. Schweiz Med Wochenschr. 1953; 37:864.
65. Eaton LW, Bulkley BH. Expansion of acute myocardial infarction: its relationship to infarct morphology in a canine model. Circ Res. 1981;49: 80-88.
66. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992; 326:287-291.
67. The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: results of the thrombolysis in myocardial ischemia (TIMI IIIA) trial. Circulation. 1993; 87:38-52.
68. Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation. 1998;97:211-218.
69. Rutsch W, Schartl M, Mathey D, Kuck K, Merx W, Dorr R, Rentrop P, Blanke H. Percutaneous transluminal coronary recanalization: procedure, results, and acute complications. Am Heart J. 1981;102:1178-1181.
70. Gormsen J, Fletcher AP, Alkjaersig N, Sherry S. Enzymatic lysis of plasma clots: the influence of fibrin stabilization on lysis rates. Arch Biochem Biophys. 1967;120:654-665.
71. Fulton WFM. The Coronary Arteries. Vol III. Springfield, Ill: Charles C. Thomas; 1965.
72. Duguid JB. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol. 1946;58:207-212.
73. Mitchell JRA, Schwartz CJ. The relation between myocardial lesions and coronary artery disease, II: a selected group of patients with massive cardiac necrosis or scarring. Br Heart J. 1963;25:1-25.
74. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
75. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
76. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999;99:1780-1787.
77. Meyer BJ, Badimon JJ, Mailhac A, Fernandez-Ortiz A, Chesebro JH, Fuster V, Badimon L. Inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy. Circulation. 1994;90:2432-2438.
78. Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovic M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1054.
79. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83: 836-844.
80. Moller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb. 1991;11:344-350.
81. Tracy RP, Bovill EG. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 1992;116:1307-1312.
82. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis. 1993;100:1-12.
83. Miller GJ. Hemostasis and cardiovascular risk: the British and European experience. Arch Pathol Lab Med. 1992;116:1318-1321.
84. Brook JG, Aviram M. Platelet lipoprotein interactions. Semin Thromb Hemost. 1988;14:258-265.
85. Weis JR, Pitas RE, Wilson BD, Rodgers GM. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 1991;5:2459-2465.
86. Andersen P, Arnesen H, Hjermann I. Hyperlipoproteinemia and reduced fibrinolytic activity in healthy coronary high-risk men. Acta Med Scand. 1981;209:199-202.
87. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990; 10:1067-1073.
88. Marder VJ, Shulman NR. High molecular weight derivatives of human fibrinogen produced by plasmin. II: mechanism of their anticoagulant activity. J Biol Chem. 1969;244:2120-2124.
89. Gold HK, Garabedian SM, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, Leinbach RC. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: observations in animals and humans. Circulation. 1997;95:1755-1759.
90. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AJJ, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van der Werf F, Braunwald E, for the TIMI-14 Investigators. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI 14) trial. Circulation. 1999;99:2720-2732.
91. Anand SS, Yusuf S, Pogue J, Weitz JI, Flather M. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction. Circulation. 1998;98:1064-1070.
92. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989;63: 114E-120E.
93. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation. 1993; 87:1179-1187.
94. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69: 377-381.
95. Moreno PR, Falk P, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.